Problem
Montara Therapeutics developed BrainOnly, a platform that keeps drugs active exclusively in the brain. Once the drug leaves the brain, it becomes inactive. This reduces side effects dramatically.
The science is elegant. But explaining it to investors? That was the challenge.
How do you show a drug that turns “off” outside the brain – without losing people in the details?
Solution
We created an investor pitch animation that walks through the BrainOnly platform step by step.
The animation shows:
- How traditional drugs stay active throughout the body (causing side effects)
- How BrainOnly drugs are designed to deactivate once they leave the brain
- Why this matters for patients and for the market
Short. Visual. Easy to follow before or during an investor meeting.
Results
“The animation clarified the science for investors in ways slides couldn’t.”
— Nicholas Hertz, CEO, Montara Therapeutics
“We use it in every investor conversation now.”
— Max Lebovitz, CFO, Montara Therapeutics
Need an investor pitch animation for your biotech?
We help biotech companies explain complex science in 90 seconds. Book a call to see if an investor pitch animation could work for your next raise.
